1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Competitor Analysis: Cancer Peptides

Competitor Analysis: Cancer Peptides

  • November 2014
  • -
  • La Merie Publishing
  • -
  • 99 pages

Competitor Analysis: Cancer Peptides


The Competitive Intelligence Report Cancer Peptides as of November 2014 provides a competitor analysis in the product portfolios and development pipeline of peptide therapeutics for treatment of cancer. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.


Therapeutic cancer peptide therapeutics in total represent a considerable market size of more than US$ 8 bln in the year 2013. Major cancer peptide products are of the classes of somatostatin analogs and agonists and antagonists of the gonadotropin releasing hormone (GnRH), but also of targeted cancer therapy including proteasome and HDAC inhibition.


The report provides a compilation of currently major marketed peptide cancer products and active projects in research and development for novel cancer peptides. Competitor projects are listed in a tabular format providing information on:



  • Drug Codes

  • Target / Mechanism of Action

  • Class of Compound

  • Company

  • Product Category

  • Indication,

  • R&D Stage and

  • additional comments with a hyperlink leading to the source of information.


About Competitor Analysis Series:


The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced


Table Of Contents

Competitor Analysis: Cancer Peptides

Competitor Analysis: Cancer Peptides


Table of Contents:



  • 2013 Sales of Major Cancer Peptides

  • Somatostatin Analogs

  • GnRH Analogs: Agonists

  • GnRH Analogs: Antagonists

  • Targeted Cancer Peptides: Proteasome Inhibition

  • Targeted Cancer Peptides: HDAC Inhibition

  • Cytotoxic, Cytostatic or Apoptotic Cancer Peptides

  • Cancer Peptide-Drug Conjugates and Peptide Fusion Proteins

  • Other Cancer Peptides

  • Corporate Cancer Peptide Randamp;D Pipelines


View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

2016 Europe Tumor Marker Testing in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppl

  • $ 34500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 28-country survey from VPGMarketResearch.com contains over 925 pages and 366 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

Global and Chinese Progesterone Industry, 2017 Market Research Report

Global and Chinese Progesterone Industry, 2017 Market Research Report

  • $ 3000
  • Industry report
  • February 2017
  • by Prof Research

The ’Global and Chinese Progesterone Industry, 2012-2022 Market Research Report’ is a professional and in-depth study on the current state of the global Progesterone industry with a focus on the Chinese ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in China

  • February 2017
    8 pages
  • Therapy  

    Contraceptive  

  • China  

View report >

Hormone and Therapy Market in Pakistan and the US

  • February 2017
    7 pages
  • Hormone  

    Therapy  

    Diabetes  

  • Pakistan  

    United States  

View report >

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Related Market Segments :

Hormone
Therapy
Cancer
Pharmaceutical

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.